Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Influenza Virus Like Particles (VLPs): Opportunities for H7N9 Vaccine Development

Viruses(2020)10.3390/v12050518Source: DataRank Database

Influenza Virus Like Particles (VLPs): Opportunities for H7N9 Vaccine Development is a research paper published in Viruses (2020). On theSindex it has a DataRank of 0. It has been cited 41 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access41 citations

Download PDF

Cite:

Linked data & code

gen nct doi pdb

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 3.97)OA: goldTopics (57)IDs (PubMed, PMC, OpenAlex)Annotations (4)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

Irina Tretyakova,Peter Pushko ORCID

Live enrichment

PubMed:32397182 PMC:PMC7291233 OpenAlex:https://openalex.org/W3021551372

National Institutes of Health

Grant: R43AI136220

National Institutes of Health

Grant: 1R43AI136220-01A1

Multivalent emergency vaccine against pandemic influenza

FWCI

3.97

Citation Percentile

0.9%

Citation Trend

2019

2020

2021

2022

2023

2024

2025

goldLicense: cc-by

journalhttps://www.mdpi.com/1999-4915/12/5/518/pdf?version=1588937812

publisherhttps://www.mdpi.com/1999-4915/12/5/518/pdf?version=1588937812

publisherhttps://www.mdpi.com/1999-4915/12/5/518/pdf

journalhttps://doi.org/10.3390/v12050518

repositoryhttps://pubmed.ncbi.nlm.nih.gov/32397182

Fields of Study

Influenza Virus Research StudiesRespiratory viral infections researchTransgenic Plants and Applications0301 basic medicine0303 health sciences03 medical and health sciencesAnimalsAntigens, ViralClinical Trials as TopicEpitopesHistocompatibility Antigens Class IIHumansInfluenza A Virus, H7N9 SubtypeInfluenza VaccinesVaccines, Virus-Like Particle

MeSH Terms

AnimalsEpitopesHistocompatibility Antigens Class IIAntigens, ViralClinical Trials as TopicHumansInfluenza VaccinesVaccines, Virus-Like ParticleInfluenza A Virus, H7N9 Subtype

Keywords

PandemicImmunogenicityVirologyVirusBiologyVirus-like particleImmunityInfluenza A virus subtype H5N1DiseaseImmunologyMedicineCoronavirus disease 2019 (COVID-19)Infectious disease (medical specialty)Immune systemRecombinant DNAGeneAvian FluPandemic Influenza AH7n9IavVlp VaccineClinical Trials as TopicHistocompatibility Antigens Class IIReviewInfluenza A Virus, H7N9 SubtypeMicrobiologyQR1-502EpitopesInfluenza VaccinesAnimalsHumansVaccines, Virus-Like ParticleAntigens, Viral

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Influenza Virus Like Particles (VLPs): Opportunities for H7N9 Vaccine Development

FAIR Checklist

Authors (2)

Funding (2 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)